omeprazole has been researched along with Dengue in 1 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Dengue: An acute febrile disease transmitted by the bite of AEDES mosquitoes infected with DENGUE VIRUS. It is self-limiting and characterized by fever, myalgia, headache, and rash. SEVERE DENGUE is a more virulent form of dengue.
Excerpt | Relevance | Reference |
---|---|---|
" Dengue patients manifested the same pharmacokinetic responses to a 20 g Ala-Gln bolus as healthy controls." | 5.31 | The pharmacokinetic responses of humans to 20 g of alanyl-glutamine dipeptide differ with the dosing protocol but not with gastric acidity or in patients with acute Dengue fever. ( Fürst, P; Klassen, P; Mazariegos, M; Solomons, NW, 2000) |
" Dengue patients manifested the same pharmacokinetic responses to a 20 g Ala-Gln bolus as healthy controls." | 1.31 | The pharmacokinetic responses of humans to 20 g of alanyl-glutamine dipeptide differ with the dosing protocol but not with gastric acidity or in patients with acute Dengue fever. ( Fürst, P; Klassen, P; Mazariegos, M; Solomons, NW, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Klassen, P | 1 |
Mazariegos, M | 1 |
Solomons, NW | 1 |
Fürst, P | 1 |
1 other study available for omeprazole and Dengue
Article | Year |
---|---|
The pharmacokinetic responses of humans to 20 g of alanyl-glutamine dipeptide differ with the dosing protocol but not with gastric acidity or in patients with acute Dengue fever.
Topics: Administration, Oral; Adolescent; Adult; Alanine; Anti-Ulcer Agents; Area Under Curve; Case-Control | 2000 |